Biophytis SA ROE Ratio 2011-2026 | BPTS

Annual ROE Ratio Biophytis SA

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
437.8	1267.19	-	-751.94	214.73	-199.64	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
1267.19	-751.94	193.63

Quarterly ROE Ratio Biophytis SA

2023-Q4	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
437.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
437.8	437.8	437.8

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-528.29	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	-32.54	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	4.58	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	-55.55	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Alpine Immune Sciences ALPN	-9.81	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	332.81	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	21.0	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	23.28	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-380.03	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	30.52	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	-1.17	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	3750.6	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-55.98	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	-183.26	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	-30.26	$ 49.8	-0.86 %	$ 4.48 B	Schweiz
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-88.4	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-948.23	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-69.02	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	-49.08	$ 31.27	4.37 %	$ 2.08 B	USA
Generation Bio Co. GBIO	-152.74	-	-	$ 344 M	USA
IMV IMV	575.45	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	43.82	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	-169.75	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	-44.16	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	-7.58	$ 14.72	-	$ 211 M	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Enlivex Therapeutics Ltd. ENLV	63.85	$ 0.67	-6.8 %	$ 30.6 M	Israel
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	-175.75	$ 2.84	-0.35 %	$ 4.68 M	Israel
Forte Biosciences FBRX	-113.75	$ 17.56	0.92 %	$ 227 M	USA
Esperion Therapeutics ESPR	7.51	$ 3.15	-	$ 655 M	USA
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	-19.38	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	-146.95	-	-	$ 28.6 M	USA